89 related articles for article (PubMed ID: 23417197)
1. Monitoring tumor proliferative response to radiotherapy using (18)F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67.
Fatema CN; Zhao S; Zhao Y; Murakami M; Yu W; Nishijima K; Tamaki N; Kitagawa Y; Kuge Y
Ann Nucl Med; 2013 May; 27(4):355-62. PubMed ID: 23417197
[TBL] [Abstract][Full Text] [Related]
2. Dual tracer evaluation of dynamic changes in intratumoral hypoxic and proliferative states after radiotherapy of human head and neck cancer xenografts using radiolabeled FMISO and FLT.
Fatema CN; Zhao S; Zhao Y; Yu W; Nishijima K; Yasuda K; Kitagawa Y; Tamaki N; Kuge Y
BMC Cancer; 2014 Sep; 14():692. PubMed ID: 25245041
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic validation of 3'-deoxy-3'-18F-fluorothymidine PET for detecting tumor repopulation during fractionated radiotherapy of human FaDu squamous cell carcinoma in nude mice.
Yue JB; Yang J; Liu J; Lee J; Cabrera AR; Sun XD; Bai GH; Li YH; Yu JM
Radiother Oncol; 2014 Jun; 111(3):475-81. PubMed ID: 24813091
[TBL] [Abstract][Full Text] [Related]
4. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
[TBL] [Abstract][Full Text] [Related]
6. Predictive Value of Early-Stage Uptake of 3'-Deoxy-3'-18F-Fluorothymidine in Cancer Cells Treated with Charged Particle Irradiation.
Lin C; Kume K; Mori T; Martinez ME; Okazawa H; Kiyono Y
J Nucl Med; 2015 Jun; 56(6):945-50. PubMed ID: 25766892
[TBL] [Abstract][Full Text] [Related]
7. In-vivo Comparison of
Zhang X; Yu J; Li C; Sun X; Meng X
Sci Rep; 2017 Apr; 7():46000. PubMed ID: 28387306
[TBL] [Abstract][Full Text] [Related]
8. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
[TBL] [Abstract][Full Text] [Related]
9. 18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.
Aide N; Kinross K; Cullinane C; Roselt P; Waldeck K; Neels O; Dorow D; McArthur G; Hicks RJ
J Nucl Med; 2010 Oct; 51(10):1559-64. PubMed ID: 20847160
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the early biologic response of esophageal carcinoma after irradiation with 18F-FLT: an in-vitro and in-vivo study.
Jiang M; Huang Q; Chen P; Ruan X; Luo Z; Zhao L; Fan W; Peng T; Sun L; Wu H
Nucl Med Commun; 2014 Dec; 35(12):1212-9. PubMed ID: 25192190
[TBL] [Abstract][Full Text] [Related]
11. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Oyama N; Ponde DE; Dence C; Kim J; Tai YC; Welch MJ
J Nucl Med; 2004 Mar; 45(3):519-25. PubMed ID: 15001697
[TBL] [Abstract][Full Text] [Related]
13. Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2'-deoxy-2'-[18F]fluoro-D-glucose (FDG) and 3'-[18F]fluoro-3'-deoxythymidine (FLT).
Molthoff CF; Klabbers BM; Berkhof J; Felten JT; van Gelder M; Windhorst AD; Slotman BJ; Lammertsma AA
Mol Imaging Biol; 2007; 9(6):340-7. PubMed ID: 17643202
[TBL] [Abstract][Full Text] [Related]
14. Spatial Concordance of Tumor Proliferation and Accelerated Repopulation from Pathologic Images to 3'-[
Li C; Zhang X; Pang L; Huang Y; Gao Y; Sun X; Yu J; Meng X
Mol Imaging Biol; 2019 Aug; 21(4):713-721. PubMed ID: 30406513
[TBL] [Abstract][Full Text] [Related]
15. 18F-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients.
Hoeben BA; Troost EG; Bussink J; van Herpen CM; Oyen WJ; Kaanders JH
Nuklearmedizin; 2014; 53(2):60-6. PubMed ID: 24468965
[TBL] [Abstract][Full Text] [Related]
16. Use of 3'-deoxy-3'-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors.
Yang YJ; Ryu JS; Kim SY; Oh SJ; Im KC; Lee H; Lee SW; Cho KJ; Cheon GJ; Moon DH
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):412-9. PubMed ID: 16404598
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice.
Tseng JR; Dandekar M; Subbarayan M; Cheng Z; Park JM; Louie S; Gambhir SS
J Nucl Med; 2005 Nov; 46(11):1851-7. PubMed ID: 16269599
[TBL] [Abstract][Full Text] [Related]
18. Increased intratumoral fluorothymidine uptake levels following multikinase inhibitor sorafenib treatment in a human renal cell carcinoma xenograft model.
Murakami M; Zhao S; Zhao Y; Yu W; Fatema CN; Nishijima KI; Yamasaki M; Takiguchi M; Tamaki N; Kuge Y
Oncol Lett; 2013 Sep; 6(3):667-672. PubMed ID: 24137387
[TBL] [Abstract][Full Text] [Related]
19. The preliminary study of 18F-FLT micro-PET/CT in predicting radiosensitivity of human nasopharyngeal carcinoma xenografts.
Zheng Y; Yang Z; Zhang Y; Shi Q; Bao X; Zhang J; Yuan H; Yao Z; Hu C; Zhang Y
Ann Nucl Med; 2015 Jan; 29(1):29-36. PubMed ID: 25217247
[TBL] [Abstract][Full Text] [Related]
20. Comparison of semiquantitative fluorescence imaging and PET tracer uptake in mesothelioma models as a monitoring system for growth and therapeutic effects.
Saito Y; Furukawa T; Arano Y; Fujibayashi Y; Saga T
Nucl Med Biol; 2008 Nov; 35(8):851-60. PubMed ID: 19026946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
